Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2007
Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseasesS Wöhrer, M Troch, J Zwerina, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1991
[Effect of various factors on survival after recurrent and/or metastatic breast cancer]P Sevelda, I Kührer, C C Zielinski, et al.
Anticancer Research|June 9, 2001
Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tractM Hejna, G Hamilton, T Brodowicz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 4, 1999
Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expressionA Spittler, C M Reissner, R Oehler, et al.
Annals of Hematology|September 8, 2010
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosisW Lamm, W Willenbacher, A Lang, et al.
Anti-Cancer Drugs|April 6, 2001
Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patientsG J Locker, C Wenzel, M Schmidinger, et al.
European Journal of Cancer Care|July 19, 2008
Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapyM Grim-Stieger, M Keilani, R M Mader, et al.
Neuroendocrinology|December 1, 1994
Effect of elevated growth hormone concentrations on the phenotype and functions of human lymphocytes and natural killer cellsH Kotzmann, M Köller, S Czernin, et al.
Cancer|January 15, 1995
Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of diseaseM Krainer, H Wolf, I Michl, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Long-term influence of adjuvant therapy on natural killer cell activity in breast cancerE Tichatschek, C C Zielinski, C Müller, et al.
Pageof 16